Zhang, L., Crocker, M., Fong, L., Coussens, L. M., Lopez, C. D., Sivagnanam, S., . . . Tempero, M. Modulation of myeloid and T cells in vivo by Bruton’s tyrosine kinase inhibitor ibrutinib in patients with metastatic pancreatic ductal adenocarcinoma. BMJ Publishing Group.
Chicago Style (17th ed.) CitationZhang, Li, et al. Modulation of Myeloid and T Cells in Vivo by Bruton’s Tyrosine Kinase Inhibitor Ibrutinib in Patients with Metastatic Pancreatic Ductal Adenocarcinoma. BMJ Publishing Group.
MLA (9th ed.) CitationZhang, Li, et al. Modulation of Myeloid and T Cells in Vivo by Bruton’s Tyrosine Kinase Inhibitor Ibrutinib in Patients with Metastatic Pancreatic Ductal Adenocarcinoma. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.